Prudential Financial’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-173,911
| Closed | -$8.06M | – | 2532 |
|
2019
Q2 | $8.06M | Buy |
173,911
+22,594
| +15% | +$1.05M | 0.01% | 932 |
|
2019
Q1 | $3.69M | Sell |
151,317
-255,530
| -63% | -$6.23M | 0.01% | 1273 |
|
2018
Q4 | $5.69M | Buy |
406,847
+160,220
| +65% | +$2.24M | 0.01% | 1042 |
|
2018
Q3 | $3.75M | Buy |
246,627
+49,790
| +25% | +$757K | 0.01% | 1312 |
|
2018
Q2 | $3.3M | Sell |
196,837
-210
| -0.1% | -$3.52K | ﹤0.01% | 1406 |
|
2018
Q1 | $3.22M | Buy |
197,047
+176,690
| +868% | +$2.88M | ﹤0.01% | 1349 |
|
2017
Q4 | $261K | Buy |
20,357
+1,110
| +6% | +$14.2K | ﹤0.01% | 2191 |
|
2017
Q3 | $237K | Buy |
19,247
+290
| +2% | +$3.57K | ﹤0.01% | 2218 |
|
2017
Q2 | $159K | Buy |
18,957
+1,580
| +9% | +$13.3K | ﹤0.01% | 2274 |
|
2017
Q1 | $155K | Buy |
17,377
+590
| +4% | +$5.26K | ﹤0.01% | 2263 |
|
2016
Q4 | $148K | Buy |
16,787
+1,610
| +11% | +$14.2K | ﹤0.01% | 2273 |
|
2016
Q3 | $102K | Buy |
15,177
+920
| +6% | +$6.18K | ﹤0.01% | 2270 |
|
2016
Q2 | $51K | Buy |
14,257
+1,600
| +13% | +$5.72K | ﹤0.01% | 2271 |
|
2016
Q1 | $37K | Sell |
12,657
-1,100
| -8% | -$3.22K | ﹤0.01% | 2275 |
|
2015
Q4 | $58K | Hold |
13,757
| – | – | ﹤0.01% | 2206 |
|
2015
Q3 | $63K | Hold |
13,757
| – | – | ﹤0.01% | 2190 |
|
2015
Q2 | $99K | Sell |
13,757
-100
| -0.7% | -$720 | ﹤0.01% | 2189 |
|
2015
Q1 | $102K | Buy |
13,857
+2,600
| +23% | +$19.1K | ﹤0.01% | 2188 |
|
2014
Q4 | $53K | Sell |
11,257
-100
| -0.9% | -$471 | ﹤0.01% | 2170 |
|
2014
Q3 | $41K | Sell |
11,357
-10,869
| -49% | -$39.2K | ﹤0.01% | 2187 |
|
2014
Q2 | $101K | Buy |
22,226
+10,869
| +96% | +$49.4K | ﹤0.01% | 2341 |
|
2014
Q1 | $53K | Sell |
11,357
-200
| -2% | -$933 | ﹤0.01% | 2231 |
|
2013
Q4 | $58K | Hold |
11,557
| – | – | ﹤0.01% | 2251 |
|
2013
Q3 | $72K | Buy |
11,557
+500
| +5% | +$3.12K | ﹤0.01% | 2235 |
|
2013
Q2 | $50K | Buy |
+11,057
| New | +$50K | ﹤0.01% | 2251 |
|